Laying the foundation for Real-world evidence studies: a case study from Newfoundland and Labrador

被引：1

作者：

Badaiki, Winifred ^{[1
]}

Pyper, Evelyn ^{[2
]}

Lester, Kendra ^{[3
]}

Skeard, Janelle ^{[1
]}

Penne, Michelle ^{[4
]}

Shin, Janey ^{[2
]}

Fisher, Brenda ^{[2
]}

Hew, Huong ^{[2
]}

Gulliver, Susanne ^{[4
]}

Gulliver, Wayne ^{[4
]}

Rahman, Proton ^{[1
]}

机构：

[1] Mem Univ Newfoundland, St John, NL, Canada

[2] Janssen Inc, Toronto, ON, Canada

[3] Newfoundland & Labrador Ctr Hlth Informat, St John, NL, Canada

[4] Newlab Clin Res, St John, NL, Canada

来源：

INTERNATIONAL JOURNAL OF POPULATION DATA SCIENCE (IJPDS) | 2022年 / 7卷 / 01期

关键词：

Real world data; psoriasis; real world evidence; research partnership; Newfoundland and Labrador; RISK; DISEASE;

D O I：

10.23889/ijpds.v7i1.1690

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

The Janssen and Newfoundland and Labrador Health Innovation Partnership (JANL-HIP) was established to carry out Real-World Evidence (RWE) projects to generate evidence about disease pathways, healthcare delivery, the effects of clinical interventions. Doing so will support and influence clinical decision-making in Newfoundland and Labrador (NL). This case study describes the foundational elements necessary for a real-world evidence generation project in NL and may provide learning for the effective execution of real-world studies in other jurisdictions. It uses an ongoing project in psoriatic disease in NL to illustrate the partnership and the benefits of RWE studies. Ultimately, the JANL-HIP RWE project aims to inform decisions that will drive improvements in health outcomes, system delivery, and policy mutually beneficial to health ecosystem stakeholders.

引用

页数：8

共 35 条

[11] Psoriasis Comorbidities
Guenther, Lyn
Gulliver, Wayne
[J]. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2009, 13 : S77 - S87
[12] Han CL, 2006, J RHEUMATOL, V33, P2167
[13] Health Research Ethics Authority, 2020, HREA CORP STAT
[14] IQVIA, OUTC RES
[15] Outcomes of planned home birth with registered midwife versus planned hospital birth with midwife or physician
Janssen, Patricia A.
Saxell, Lee
Page, Lesley A.
Klein, Michael C.
Liston, Robert M.
Lee, Shoo K.
[J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2009, 181 (6-7) : 377 - 383
[16] Proceed with Caution When Using Real World Data and Real World Evidence
Kim, Hun-Sung
Kim, Ju Han
[J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2019, 34 (04)
[17] What Is Real-World Data? A Review of Definitions Based on Literature and Stakeholder Interviews
Makady, Amr
de Boer, Anthonius
Hillege, Hans
Klungel, Olaf
Goettsch, Wim
[J]. VALUE IN HEALTH, 2017, 20 (07) : 858 - 865
[18] Regulating the Secondary Use of Data for Research: Arguments Against Genetic Exceptionalism
Martani, Andrea
Genevieve, Lester Darryl
Pauli-Magnus, Christiane
McLennan, Stuart
Elger, Bernice Simone
[J]. FRONTIERS IN GENETICS, 2019, 10
[19] Long-Term Safety and Tolerability of Apremilast Versus Placebo in Psoriatic Arthritis: A Pooled Safety Analysis of Three Phase III, Randomized, Controlled Trials
Mease, Philip J.
Gladman, Dafna D.
Gomez-Reino, Juan J.
Hall, Stephen
Kavanaugh, Arthur
Lespessailles, Eric
Schett, Georg
Paris, Maria
Delev, Nikolay
Teng, Lichen
Wollenhaupt, Juergen
[J]. ACR OPEN RHEUMATOLOGY, 2020, 2 (08) : 459 - 470
[20] Miani Celine, 2014, Rand Health Q, V4, P15

← 1 2 3 4 →